| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.17e-05 | 83 | 34 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.26e-04 | 560 | 34 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.45e-04 | 566 | 34 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 9.39e-04 | 1244 | 34 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.08e-03 | 1271 | 34 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.40e-03 | 739 | 34 | 6 | GO:0003682 | |
| GeneOntologyCellularComponent | chromatin | 6.29e-05 | 1480 | 33 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | euchromatin | 1.98e-04 | 72 | 33 | 3 | GO:0000791 | |
| Domain | HMG_box | 3.94e-03 | 53 | 33 | 2 | PF00505 | |
| Domain | HMG_BOX_2 | 4.09e-03 | 54 | 33 | 2 | PS50118 | |
| Domain | HMG | 4.09e-03 | 54 | 33 | 2 | SM00398 | |
| Domain | - | 4.24e-03 | 55 | 33 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 5.87e-03 | 65 | 33 | 2 | IPR009071 | |
| Domain | - | 6.61e-03 | 218 | 33 | 3 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 8.80e-03 | 242 | 33 | 3 | IPR011991 | |
| Domain | Homeobox_metazoa | 1.10e-02 | 90 | 33 | 2 | IPR020479 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35013104 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35788130 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.08e-06 | 908 | 34 | 8 | 19274049 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 37292436 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 15999204 | ||
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 9827568 | ||
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 22020760 | ||
| Pubmed | The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling. | 9.26e-06 | 5 | 34 | 2 | 30232230 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.88e-05 | 877 | 34 | 7 | 20211142 | |
| Pubmed | SHARPIN is an endogenous inhibitor of β1-integrin activation. | 1.94e-05 | 7 | 34 | 2 | 21947080 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.85e-05 | 180 | 34 | 4 | 35198878 | |
| Pubmed | Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. | 3.33e-05 | 9 | 34 | 2 | 22723415 | |
| Pubmed | 4.15e-05 | 10 | 34 | 2 | 17998332 | ||
| Pubmed | 5.49e-05 | 75 | 34 | 3 | 15951569 | ||
| Pubmed | 6.08e-05 | 12 | 34 | 2 | 17726103 | ||
| Pubmed | 6.08e-05 | 12 | 34 | 2 | 18296617 | ||
| Pubmed | Deciphering the Sox-Oct partner code by quantitative cooperativity measurements. | 7.19e-05 | 13 | 34 | 2 | 22344693 | |
| Pubmed | 7.19e-05 | 13 | 34 | 2 | 12194848 | ||
| Pubmed | Next-generation sequencing to generate interactome datasets. | 1.03e-04 | 1147 | 34 | 7 | 21516116 | |
| Pubmed | Retinoic acid-dependent eye morphogenesis is orchestrated by neural crest cells. | 1.10e-04 | 16 | 34 | 2 | 16207763 | |
| Pubmed | Transcriptional activators differ in their abilities to control alternative splicing. | 1.10e-04 | 16 | 34 | 2 | 12221105 | |
| Pubmed | Exon structure of the nuclear factor I DNA-binding domain from C. elegans to mammals. | 1.10e-04 | 16 | 34 | 2 | 10087299 | |
| Pubmed | 1.74e-04 | 20 | 34 | 2 | 24385915 | ||
| Pubmed | 1.74e-04 | 20 | 34 | 2 | 9128241 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.76e-04 | 544 | 34 | 5 | 28473536 | |
| Pubmed | The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas. | 1.93e-04 | 21 | 34 | 2 | 16306355 | |
| Pubmed | 1.93e-04 | 21 | 34 | 2 | 30021842 | ||
| Pubmed | 3.21e-04 | 27 | 34 | 2 | 25133637 | ||
| Pubmed | 3.70e-04 | 29 | 34 | 2 | 21998595 | ||
| Pubmed | 3.95e-04 | 1429 | 34 | 7 | 35140242 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 4.24e-04 | 31 | 34 | 2 | 20516061 | |
| Pubmed | c-Jun is required for the specification of joint cell fates. | 4.24e-04 | 31 | 34 | 2 | 23475960 | |
| Pubmed | 4.84e-04 | 1049 | 34 | 6 | 27880917 | ||
| Pubmed | 5.72e-04 | 36 | 34 | 2 | 15745951 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.78e-04 | 774 | 34 | 5 | 15302935 | |
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 8.94e-04 | 45 | 34 | 2 | 34248495 | |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 9.55e-04 | 198 | 34 | 3 | 20881960 | |
| Interaction | PAX9 interactions | 2.12e-06 | 130 | 33 | 5 | int:PAX9 | |
| Interaction | KMT2D interactions | 7.67e-06 | 169 | 33 | 5 | int:KMT2D | |
| Interaction | DTX2 interactions | 1.40e-05 | 330 | 33 | 6 | int:DTX2 | |
| Interaction | ZNF608 interactions | 1.57e-05 | 93 | 33 | 4 | int:ZNF608 | |
| Interaction | NFIX interactions | 3.18e-05 | 227 | 33 | 5 | int:NFIX | |
| Interaction | SIX4 interactions | 5.79e-05 | 46 | 33 | 3 | int:SIX4 | |
| Interaction | SOX15 interactions | 8.02e-05 | 141 | 33 | 4 | int:SOX15 | |
| Interaction | NFIB interactions | 8.25e-05 | 142 | 33 | 4 | int:NFIB | |
| Interaction | ZNF609 interactions | 9.19e-05 | 146 | 33 | 4 | int:ZNF609 | |
| Interaction | BCOR interactions | 1.23e-04 | 302 | 33 | 5 | int:BCOR | |
| Interaction | KDM6A interactions | 1.37e-04 | 162 | 33 | 4 | int:KDM6A | |
| Interaction | GAREM2 interactions | 1.42e-04 | 11 | 33 | 2 | int:GAREM2 | |
| Interaction | POU2F1 interactions | 1.85e-04 | 175 | 33 | 4 | int:POU2F1 | |
| Interaction | NFIA interactions | 2.43e-04 | 188 | 33 | 4 | int:NFIA | |
| Interaction | SETD1B interactions | 2.49e-04 | 75 | 33 | 3 | int:SETD1B | |
| Interaction | GATA2 interactions | 3.02e-04 | 199 | 33 | 4 | int:GATA2 | |
| Interaction | FEV interactions | 3.25e-04 | 203 | 33 | 4 | int:FEV | |
| Interaction | TLE3 interactions | 3.40e-04 | 376 | 33 | 5 | int:TLE3 | |
| Interaction | NFIC interactions | 3.70e-04 | 210 | 33 | 4 | int:NFIC | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 4.02e-03 | 127 | 34 | 2 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 4.14e-03 | 129 | 34 | 2 | chr2q35 | |
| GeneFamily | SRY-boxes | 2.85e-04 | 19 | 24 | 2 | 757 | |
| Coexpression | LI_ESTROGENE_EARLY_E2_RESPONSE_UP | 5.09e-06 | 88 | 34 | 4 | M48213 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.68e-05 | 650 | 34 | 7 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.83e-05 | 659 | 34 | 7 | MM1040 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 4.18e-05 | 150 | 34 | 4 | M8796 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.75e-05 | 155 | 34 | 4 | M39246 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.20e-04 | 610 | 34 | 6 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.25e-04 | 615 | 34 | 6 | M8673 | |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN | 1.26e-04 | 13 | 34 | 2 | M2070 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 1.28e-04 | 200 | 34 | 4 | M7256 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP | 1.28e-04 | 200 | 34 | 4 | M5985 | |
| Coexpression | GSE3982_MAST_CELL_VS_BCELL_UP | 1.28e-04 | 200 | 34 | 4 | M5434 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP | 1.28e-04 | 200 | 34 | 4 | M9278 | |
| Coexpression | HALLMARK_ESTROGEN_RESPONSE_EARLY | 1.28e-04 | 200 | 34 | 4 | M5906 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP | 1.28e-04 | 200 | 34 | 4 | M7805 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 1.37e-04 | 77 | 34 | 3 | M40001 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 1.40e-04 | 909 | 34 | 7 | M41018 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_DN | 1.47e-04 | 14 | 34 | 2 | MM453 | |
| Coexpression | BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP | 1.57e-04 | 211 | 34 | 4 | M2230 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_DN | 1.65e-04 | 82 | 34 | 3 | M42504 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 1.71e-04 | 83 | 34 | 3 | M2448 | |
| Coexpression | KIM_WT1_TARGETS_UP | 1.74e-04 | 217 | 34 | 4 | M9128 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.89e-04 | 417 | 34 | 5 | M39224 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP | 1.97e-04 | 224 | 34 | 4 | M12383 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP | 2.11e-04 | 228 | 34 | 4 | M2151 | |
| Coexpression | TOMIDA_METASTASIS_DN | 2.47e-04 | 18 | 34 | 2 | M2583 | |
| Coexpression | FOROUTAN_TGFB_EMT_DN | 3.71e-04 | 108 | 34 | 3 | M42502 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | 3.75e-04 | 754 | 34 | 6 | M39037 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | 4.34e-04 | 775 | 34 | 6 | M45713 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 4.69e-04 | 117 | 34 | 3 | M45663 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN | 4.72e-04 | 282 | 34 | 4 | M7623 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 5.05e-04 | 120 | 34 | 3 | M42505 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-09 | 186 | 34 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-09 | 189 | 34 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.94e-07 | 198 | 34 | 5 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.94e-07 | 198 | 34 | 5 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.94e-07 | 198 | 34 | 5 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-05 | 179 | 34 | 4 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 182 | 34 | 4 | 9fc2f84bf70ad9a11c8a7326bd101e6f6cbcc33e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-05 | 187 | 34 | 4 | e1b41560c26795a7d353b9468b1bb6fc7c6b379e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-05 | 188 | 34 | 4 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 189 | 34 | 4 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 190 | 34 | 4 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 190 | 34 | 4 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 190 | 34 | 4 | a7f6c38bbf451f166febb21e6719d4afced4035e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 191 | 34 | 4 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 191 | 34 | 4 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 192 | 34 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 193 | 34 | 4 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 34 | 4 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 34 | 4 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 34 | 4 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 34 | 4 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 34 | 4 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 34 | 4 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 193 | 34 | 4 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 34 | 4 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 197 | 34 | 4 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-05 | 198 | 34 | 4 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-05 | 199 | 34 | 4 | a24a319d3ba8f4759f742af27610b4d62e359a2d | |
| ToppCell | distal-Epithelial-Differentiating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-05 | 199 | 34 | 4 | 286d52f25120293620bdbfd62b832f08e118adf6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 34 | 4 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.15e-04 | 124 | 34 | 3 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 147 | 34 | 3 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | Myeloid-C_(Monocyte)|World / shred on cell class and cell subclass (v4) | 2.09e-04 | 152 | 34 | 3 | 9145dc014ed7f154c158d454dc2b9754396afcca | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-04 | 153 | 34 | 3 | 14753baa9980f75206fefc3c8b43685fd4178a43 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 158 | 34 | 3 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 158 | 34 | 3 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 158 | 34 | 3 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 158 | 34 | 3 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 158 | 34 | 3 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 158 | 34 | 3 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 162 | 34 | 3 | 465cb483f41023d6125ea147e16f404d8e8dc9bb | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 2.57e-04 | 163 | 34 | 3 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-04 | 163 | 34 | 3 | 22fa5d017ff796394394d952ec151e2d1beb8248 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.62e-04 | 164 | 34 | 3 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.62e-04 | 164 | 34 | 3 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-ILC3|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 164 | 34 | 3 | 631ec9f54475dcc9d6b1c5bf6917e7fda4671034 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 164 | 34 | 3 | 24fdea5113d92b96f56b06dd2449910a3c785e69 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.76e-04 | 167 | 34 | 3 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 168 | 34 | 3 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 168 | 34 | 3 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-04 | 170 | 34 | 3 | 9a47d03f7eea6299a836a0eb1e7c1252c03f76df | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-04 | 170 | 34 | 3 | 4252c0a335762508bd1f8f71c6e78a657d7df125 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-04 | 170 | 34 | 3 | 0aa11d8cb44403b6769860dac2d3b05da6fff79d | |
| ToppCell | PND07-Immune-Immune_Myeloid|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-04 | 171 | 34 | 3 | f68cbfa2eb1f39401a31dbd9b630023249406098 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 172 | 34 | 3 | d098e8a9c7666354803225cf2650faad436bab66 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 173 | 34 | 3 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-04 | 173 | 34 | 3 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 174 | 34 | 3 | 319bfafc66a21ad05ab35e0fd024c8b372a07165 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 3.11e-04 | 174 | 34 | 3 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 174 | 34 | 3 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 175 | 34 | 3 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.17e-04 | 175 | 34 | 3 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 175 | 34 | 3 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-04 | 176 | 34 | 3 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | PND07-Immune|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-04 | 176 | 34 | 3 | 2f87f49b64c6f89823d540172a8e923ebaa6d6cd | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.22e-04 | 176 | 34 | 3 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 3.27e-04 | 177 | 34 | 3 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 177 | 34 | 3 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | b860013f1fd397400a62d66ab521cfc81349ffe2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-04 | 178 | 34 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-04 | 178 | 34 | 3 | b89c4d015b44bf538aa39969ef8778877c8023f1 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-04 | 178 | 34 | 3 | c30d3390fc4a7856f50ba8ff6694c0333165ddde | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-04 | 178 | 34 | 3 | fb8f8d95f6b08378fb42c4076ee040276faa296f | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 178 | 34 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-04 | 179 | 34 | 3 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 3.38e-04 | 179 | 34 | 3 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-04 | 179 | 34 | 3 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-04 | 179 | 34 | 3 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.38e-04 | 179 | 34 | 3 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 3.38e-04 | 179 | 34 | 3 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.44e-04 | 180 | 34 | 3 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.44e-04 | 180 | 34 | 3 | 6c0115d03ec58bc7ae5317bf8906617489975351 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.50e-04 | 181 | 34 | 3 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.50e-04 | 181 | 34 | 3 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.50e-04 | 181 | 34 | 3 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.50e-04 | 181 | 34 | 3 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.50e-04 | 181 | 34 | 3 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.55e-04 | 182 | 34 | 3 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.55e-04 | 182 | 34 | 3 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| Drug | 1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.05e-05 | 197 | 34 | 5 | 22_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.05e-05 | 197 | 34 | 5 | 4299_UP | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.62e-04 | 185 | 34 | 4 | 4542_UP | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.72e-04 | 188 | 34 | 4 | 4296_UP | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 1.76e-04 | 189 | 34 | 4 | 3084_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.79e-04 | 190 | 34 | 4 | 4274_UP | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; HL60; HG-U133A | 1.83e-04 | 191 | 34 | 4 | 1562_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; PC3; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 6684_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 5222_DN | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 4306_UP | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 7247_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 6171_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 2672_DN | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 6066_UP | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HG-U133A | 1.98e-04 | 195 | 34 | 4 | 1883_DN | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 6129_DN | |
| Drug | LY294002; Down 200; 10uM; MCF7; HG-U133A | 2.02e-04 | 196 | 34 | 4 | 328_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 6182_DN | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 7071_UP | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 5778_DN | |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 4408_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 2667_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 6741_DN | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 3088_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 2718_UP | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A | 2.06e-04 | 197 | 34 | 4 | 1751_UP | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 7253_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 1303_UP | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6632_UP | |
| Drug | sulindac; Down 200; 50uM; MCF7; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 307_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 1178_UP | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6300_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; PC3; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 1934_UP | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 3995_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 3710_UP | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 7501_DN | |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; HL60; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 2497_UP | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 2.14e-04 | 199 | 34 | 4 | 309_DN | |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 6420_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 6489_UP | |
| Drug | N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt; Up 200; 20uM; MCF7; HG-U133A | 2.18e-04 | 200 | 34 | 4 | 591_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 2.18e-04 | 200 | 34 | 4 | 1164_UP | |
| Disease | forced expiratory volume | 2.54e-04 | 789 | 34 | 6 | EFO_0004314 | |
| Disease | plasminogen activator inhibitor 1 measurement | 1.78e-03 | 54 | 34 | 2 | EFO_0004792 | |
| Disease | FEV/FEC ratio | 2.54e-03 | 1228 | 34 | 6 | EFO_0004713 | |
| Disease | erythrocyte measurement | 3.20e-03 | 257 | 34 | 3 | EFO_0005047 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSSKPSPIYISSYSS | 1086 | Q99569 | |
| AFPSYAGSLPTSSSY | 286 | Q9BUH8 | |
| GSPSSYNSSSSSPRY | 181 | Q9H201 | |
| SPYISSVQSYPGSAS | 81 | P56177 | |
| PYSSSTLPHGSSYSL | 181 | Q9NZM3 | |
| STLITTVGYGYTTPL | 101 | Q9Y257 | |
| SYGASSLPDKTYTSP | 41 | P31267 | |
| GSGPYSAPSPAYSSS | 236 | Q00613 | |
| TRSPSPTLSYYSSGL | 561 | Q9H706 | |
| VPTTSTGYQPAYTTS | 476 | Q9HBW1 | |
| SGSSYGSISSPTSPT | 11 | P49279 | |
| SNGYPVLYPTGLSSS | 1011 | P56199 | |
| TTPESPPYSSGSYDS | 126 | Q96MY1 | |
| SLPSGAYYGSGTPSS | 1916 | P16112 | |
| AYYGSGTPSSFPTVS | 1921 | P16112 | |
| GAYSPGQSSLYSSPC | 351 | Q12948 | |
| SSGYFSSSPTLSSSP | 286 | Q8TB45 | |
| GPAYSSYSTLTGSLT | 21 | O60759 | |
| YPGSSCGSSYPSNLV | 21 | Q3SY46 | |
| ITPGSGSIYSSPGLY | 171 | Q96AC1 | |
| GTSIPTSTYTEGSTP | 321 | Q685J3 | |
| SSFSTSPTGQSPYTY | 121 | O00167 | |
| SSGLPYASSLGYPTA | 186 | Q9Y651 | |
| FSTPALYIYTSGTTG | 216 | O14975 | |
| GSPSSYSPSTGVGFS | 901 | Q9Y2K2 | |
| SSSSPGYPLTSGTVY | 331 | Q9NT68 | |
| GGDYYTSPSSPTSSS | 296 | P08651 | |
| TPYTSRGSTPYSQDS | 271 | O15047 | |
| PSYSTAYLPGSYGSS | 166 | O60248 | |
| GQPASTLSSGYTYPT | 156 | Q9UPR6 | |
| SYAPSSPSSSNSGSY | 221 | Q9NX95 | |
| TSPTYSPTSPKGSTY | 1926 | P24928 | |
| KGSTYSPTSPGYSPT | 1936 | P24928 | |
| GYSPTSPTYSLTSPA | 1946 | P24928 | |
| YQSSSPLPTVGSSYS | 1131 | Q9HBL0 | |
| PLPTVGSSYSSPDYS | 1136 | Q9HBL0 | |
| PSSYSFSPYGSKVSG | 1261 | O15014 | |
| AVGTGSSYPTTTISY | 201 | P17275 |